The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
DESCRIPTION: In February 2022, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline (CPG) for the management of major depressive disorder (MDD). This synopsis summarizes key recommendations. METHODS: Senior leaders within the VA and the DoD assembled a team to update the 2016 CPG for the management of MDD that included clinical stakeholders and conformed to the National Academy of Medicine's tenets for trustworthy CPGs. The guideline panel developed key questions, systematically searched and evaluated the literature, created two 1-page algorithms, and distilled 36 recommendations for care using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Select recommendations that were identified by the authors to represent key changes from the prior CPG are presented in this synopsis. RECOMMENDATIONS: The scope of the CPG is diverse; however, this synopsis focuses on key recommendations that the authors identified as important new evidence and changes to prior recommendations on pharmacologic management, pharmacogenomics, psychotherapy, complementary and alternative therapies, and the use of telemedicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363
Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K., Meerpohl, J. J., Coello, P. A., Rind, D., Montori, V. M., Brito, J. P., Norris, S., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,315
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301
Karyotaki, E., Efthimiou, O., Miguel, C., Maas genannt Bermpohl, F., Furukawa, T. A., Cuijpers, P., Individual Patient Data Meta-Analyses for Depression (IPDMA-DE) Collaboration, Riper, H., Patel, V., Mira, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.4364 · Cited by 866
Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Lim, P., Duca, A. R., Hough, D., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1189 · Cited by 795
Effects of evidence-based clinical practice guidelines on quality of care: a systematic review
Lugtenberg, M., Burgers, J. S., & Westert, G. P. (2009) · Quality and Safety in Health Care · doi:10.1136/qshc.2008.028043 · Cited by 478
Ionescu, D. F., Fu, D.-J., Qiu, X., Lane, R., Lim, P., Kasper, S., Hough, D., Drevets, W. C., Manji, H., & Canuso, C. M. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa068 · Cited by 418 · cited 1×
“However, the effectiveness of esketamine in preventing suicide or reducing suicidal ideation or behavior has not been established (35, 36).”
BackgroundFu, D.-J., Ionescu, D. F., Li, X., Lane, R., Lim, P., Sanacora, G., Hough, D., Manji, H., Drevets, W. C., & Canuso, C. M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m13191 · Cited by 376 · cited 1×
“However, the effectiveness of esketamine in preventing suicide or reducing suicidal ideation or behavior has not been established (35, 36).”
BackgroundTreatment of Adult Depression in the United States
Olfson, M., Blanco, C., & Marcus, S. C. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5057 · Cited by 352 · cited 1×
“households found that only 29%of persons who screened positive for depression received treatment (3).”
BackgroundGaynes, B. N., Lloyd, S. W., Lux, L., Gartlehner, G., Hansen, R. A., Brode, S., Jonas, D. E., Evans, T. S., Viswanathan, M., & Lohr, K. N. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08815 · Cited by 347
Greden, J. F., Parikh, S. V., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Mondimore, F. M., Shelton, R. C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.01.003 · Cited by 347 · cited 1×
“Although there was evidence suggesting some benefit to pharmacogenetic matching (40, 41), the work group determined that it was not enough to make a recommendation.”
BackgroundKetamine administration in depressive disorders: a systematic review and meta-analysis
Fond, G., Loundou, A., Rabu, C., Macgregor, A., Lançon, C., Brittner, M., Micoulaud-Franchi, J.-A., Richieri, R., Courtet, P., Abbar, M., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3664-5 · Cited by 339
Wajs, E., Aluisio, L., Holder, R., Daly, E. J., Lane, R., Lim, P., George, J. E., Morrison, R. L., Sanacora, G., Young, A. H., et al. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m12891 · Cited by 308 · cited 1×
“Although there is evidence to support longer-term maintenance use of esketamine, it too has been primarily studied in patients who have previously not responded to trials of antidepressants (37, 38).”
BackgroundLam, R. W., Chan, P., Wilkins-Ho, M., & Yatham, L. N. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300909 · Cited by 297
Qaseem, A., Barry, M. J., Kansagara, D., & for the Clinical Guidelines Committee of the American College of Physicians (2016) · Annals of Internal Medicine · doi:10.7326/m15-2570 · Cited by 279
Lieverse, R., Van Someren, E. J. W., Nielen, M. M. A., Uitdehaag, B. M. J., Smit, J. H., & Hoogendijk, W. J. G. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.183 · Cited by 261
A Randomized, Double-Blind, Placebo-Controlled Study of Light Therapy for Antepartum Depression
Wirz-Justice, A., Bader, A., Frisch, U., Stieglitz, R.-D., Alder, J., Bitzer, J., Hösli, I., Jazbec, S., Benedetti, F., Terman, M., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06188blu · Cited by 241
Egede, L. E., Acierno, R., Knapp, R. G., Lejuez, C., Hernandez-Tejada, M., Payne, E. H., & Frueh, B. C. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00122-4 · Cited by 177
Yesavage, J. A., Fairchild, J. K., Mi, Z., Biswas, K., Davis-Karim, A., Phibbs, C. S., Forman, S. D., Thase, M., Williams, L. M., Etkin, A., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.1483 · Cited by 164
Kryst, J., Kawalec, P., Mitoraj, A. M., Pilc, A., Lasoń, W., & Brzostek, T. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00097-z · Cited by 159 · cited 2×
“Ketamine and esketamine are not recommended as initial treatment but are reserved for patients for whom previous therapies have failed or who have not tolerated previous therapies (32).”
BackgroundRosenblat, J. D., Lee, Y., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.056 · Cited by 135
Light therapy in non-seasonal depression: An update meta-analysis
Tao, L., Jiang, R., Zhang, K., Qian, Z., Chen, P., Lv, Y., & Yao, Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113247 · Cited by 129
Gibbons, M. B. C., Gallop, R., Thompson, D., Luther, D., Crits-Christoph, K., Jacobs, J., Yin, S., & Crits-Christoph, P. F. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1720 · Cited by 112
Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis
Papakostas, G. I., Salloum, N. C., Hock, R. S., Jha, M. K., Murrough, J. W., Mathew, S. J., Iosifescu, D. V., & Fava, M. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r12889 · Cited by 108
Luxton, D. D., Pruitt, L. D., Wagner, A. W., Smolenski, D. J., Jenkins‐Guarnieri, M. A., & Gahm, G. A. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000135 · Cited by 86
Liu, H., & Au-Yeung, S. S. Y. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.04.012 · Cited by 70
Callesen, P., Reeves, D., Heal, C., & Wells, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-64577-1 · Cited by 55
Psychotherapy for Depression in Older Veterans Via Telemedicine
Egede, L. E., Acierno, R. E., Knapp, R. G., Walker, R. J., Payne, E. H., & Frueh, B. C. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m10951 · Cited by 50
McGregor, B., Li, C., Baltrus, P., Douglas, M., Hopkins, J., Wrenn, G., Holden, K., Respress, E., & Gaglioti, A. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900407 · Cited by 50
Driessen, E., Van, H. L., Peen, J., Don, F. J., Twisk, J. W. R., Cuijpers, P., & Dekker, J. J. M. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000207 · Cited by 48
Chou, P., Lu, M., Tsai, C., Hsieh, W., Lai, H.-C., Shityakov, S., & Su, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.06.024 · Cited by 38
Giosan, C., Cobeanu, O., Wyka, K., Muresan, V., Mogoaşe, C., Szentágotai, A., Malta, L. S., & Moldovan, R. (2020) · Journal of Clinical Psychology · doi:10.1002/jclp.22991 · Cited by 7
Cited by
Jha, M. K., & Mathew, S. J. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230025 · Cited by 114
Schnurr, P. P., Hamblen, J. L., Wolf, J., Coller, R., Collie, C. F., Fuller, M. A., Holtzheimer, P. E., Kelly, U. A., Lang, A. J., McGraw, K., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2757 · Cited by 111
“Evidence was insuf-fi cient to make a recommendation for or against other technological methods, such as mobile apps (recommendations 30 and 31).”
MethodSelf-citationCrowley, M. J., Tarkington, P. E., Bosworth, H. B., Jeffreys, A. S., Coffman, C. J., Maciejewski, M. L., Steinhauser, K., Smith, V. A., Dar, M. S., Fredrickson, S. K., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.2947 · Cited by 75
New and emerging treatments for major depressive disorder
Njenga, C., Ramanuj, P., de Magalhães, F. J. C., & Pincus, H. A. (2024) · BMJ · doi:10.1136/bmj-2022-073823 · Cited by 59
“79 The guidelines also recommend the use of rTMS in such patients but not TBS, concluding that the strength of the evidence is too low to justify a recommendation.”
BackgroundPharmacogenomic Clinical Support Tools for the Treatment of Depression
Baum, M. L., Widge, A. S., Carpenter, L. L., McDonald, W. M., Cohen, B. M., & Nemeroff, C. B. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230657 · Cited by 36
Metadata
- Authors
- McQuaid, J. R., Buelt, A., Capaldi, V., Fuller, M., Issa, F., Lang, A. E., Hoge, C., Oslin, D. W., Sall, J., Wiechers, I. R., & Williams, S.
- Affiliations
- University of California, San Francisco (US)
- C.W. Bill Young VA Medical Center (US)
- Uniformed Services University of the Health Sciences (US)
- United States Department of Veterans Affairs (US)
- Defense Health Agency (US)
- Virginia Commonwealth University (US)
- Walter Reed Army Institute of Research (US)
- Philadelphia VA Medical Center (US)
- Veterans Administration (US)
- Case Western Reserve University (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2022-10
- Volume
- 175
- Issue
- 10
- Pages
- 1440-1451
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W4296460212
- Semantic Scholar
- 174bc4c3e69c5fa6b69648ea0d34dd50176ed02e
- Cited by
- 59
- References
- 36
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 12 · 2023: 8 · 2022: 3
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- major depressive disorder, veterans, pharmacological management, pharmacogenomics, psychotherapy, complementary and alternative medicine, telemedicine, guideline recommendations
- MeSH terms
- Major Depressive Disorder, Humans, United States, United States Department of Veterans Affairs, Veterans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.